BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 2142838)

  • 1. Activation of CD8+ T cells by allogeneic class II-deficient B-cell lines derived from patients with bare lymphocyte syndrome.
    Jin Z; Yang SY
    Tissue Antigens; 1990 Mar; 35(3):136-43. PubMed ID: 2142838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in surface phenotype and mechanism of action between alloantigen-specific CD8+ cytotoxic and suppressor T cell clones.
    Koide J; Engleman EG
    J Immunol; 1990 Jan; 144(1):32-40. PubMed ID: 1967266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic T-T cell interaction present in alloreactivity: determination of 'MLR helper' T cell subsets.
    Asano Y; Komuro T; Tada T
    Int Immunol; 1990; 2(12):1203-11. PubMed ID: 1982500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A human melanoma cell line, recognized by both HLA class I and class II restricted T cells, is capable of initiating both primary and secondary immune responses.
    Olsen AC; Fossum B; Kirkin AF; Zeuthen J; Gaudernack G
    Scand J Immunol; 1995 Apr; 41(4):357-64. PubMed ID: 7899823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles virus-specific human T cell clones. Characterization of specificity and function of CD4+ helper/cytotoxic and CD8+ cytotoxic T cell clones.
    van Binnendijk RS; Poelen MC; de Vries P; Voorma HO; Osterhaus AD; Uytdehaag FG
    J Immunol; 1989 Apr; 142(8):2847-54. PubMed ID: 2467943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
    Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
    J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of CD4+ T cells involved in anti-allo-class I H-2 immune responses. Functional discrimination between the major proliferating cells and helper cells assisting cytotoxic T cell responses.
    Kitagawa S; Sato S; Azuma T; Shimizu J; Hamaoka T; Fujiwara H
    J Immunol; 1991 Apr; 146(8):2513-21. PubMed ID: 1673140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of HLA-restricted EBV-specific cytotoxic T cells does not require CD4+ (helper) T cells or exogenous cytokines.
    Fishwild DM; Benike CJ; Engleman EG
    J Immunol; 1988 Mar; 140(6):1994-8. PubMed ID: 2831276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T helper-independent activation of human CD8+ cells: the role of CD28 costimulation.
    Van Gool SW; Zhang Y; Kasran A; de Boer M; Ceuppens JL
    Scand J Immunol; 1996 Jul; 44(1):21-9. PubMed ID: 8693288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences between primed allogeneic T-cell responses and the primary mixed leucocyte reaction. Primed T cells become independent of the blocking effects of monoclonal antibodies against IL-1 beta and the CD5, CD11a (LFA-1), and CD11c (p 150,95) molecules.
    Odum N; Hofmann B; Morling N; Platz P; Ryder LP; Tvede N; Geisler C; Svejgaard A
    Scand J Immunol; 1988 Apr; 27(4):405-11. PubMed ID: 2966435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of two distinct primary T cell populations that secrete interleukin 2 upon recognition of class I or class II major histocompatibility antigens.
    Mizuochi T; Ono S; Malek TR; Singer A
    J Exp Med; 1986 Mar; 163(3):603-19. PubMed ID: 2936862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human T cell receptor-gamma delta-expressing T-cell lines recognize MHC-controlled elements on autologous EBV-LCL that are not HLA-A, -B, -C, -DR, -DQ, or -DP.
    Lam V; DeMars R; Chen BP; Hank JA; Kovats S; Fisch P; Sondel PM
    J Immunol; 1990 Jul; 145(1):36-45. PubMed ID: 1694208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal skin-derived MHC class I+, MHC class II- dendritic cells stimulate MHC class I-restricted responses of unprimed CD8+ T cells.
    Elbe A; Schleischitz S; Strunk D; Stingl G
    J Immunol; 1994 Oct; 153(7):2878-89. PubMed ID: 7522244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuraminidase-treated macrophages stimulate allogenic CD8+ T cells in the presence of exogenous interleukin 2.
    Hirayama Y; Inaba K; Inaba M; Kato T; Kitaura M; Hosokawa T; Ikehara S; Muramatsu S
    J Exp Med; 1988 Oct; 168(4):1443-56. PubMed ID: 3262711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE; Spits H
    J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic T lymphocyte precursor cells specific for the major histocompatibility complex class I-like antigen, Qa-2, require CD4+ T cells to become primed in vivo and to differentiate into effector cells in vitro.
    Muraoka S
    Eur J Immunol; 1991 Sep; 21(9):2095-103. PubMed ID: 1679712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human allogeneic melanoma-reactive T-helper lymphocyte clones: functional analysis of lymphocyte-melanoma interactions.
    Radrizzani M; Benedetti B; Castelli C; Longo A; Ferrara GB; Herlyn M; Parmiani G; Fossati G
    Int J Cancer; 1991 Dec; 49(6):823-30. PubMed ID: 1835714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of Epstein-Barr virus-specific, HLA class II-restricted CD4+ cytotoxic T lymphocytes in infectious mononucleosis.
    Enssle KH; Fleischer B
    Clin Exp Immunol; 1990 Mar; 79(3):409-15. PubMed ID: 1690617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the donor-specific cytotoxic T lymphocyte repertoire in a patient with a long term surviving allograft. Frequency, specificity, and phenotype of donor-reactive T cell receptor (TCR)-alpha beta+ and TCR-gamma delta+ clones.
    Vandekerckhove BA; Datema G; Koning F; Goulmy E; Persijn GG; Van Rood JJ; Claas FH; De Vries JE
    J Immunol; 1990 Feb; 144(4):1288-94. PubMed ID: 2137487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
    Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
    J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.